We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Blocked Membrane Translocators Initiate Cell Death Response

By LabMedica International staff writers
Posted on 04 Sep 2009
A team of molecular biologists has shown that certain antibiotics that kill bacteria by inhibiting protein transcription also cause the blockage and destruction of translocators, microtubules that transport macromolecules through organelle and cell membranes.

Investigators from Princeton University (NJ, USA) studied the Sec complex of translocators in Escherichia coli. More...
They found that the antibiotics tetracycline and chloramphenicol, which inhibit ribosomal function, generated ribosome-polypeptide particles that became stuck in the translocators and plugged them up. In response, the cell activated the protease FtsH, which digested portions of the translocators and contributed to death of the cells. Increasing the amounts or the stability of the membrane protein YccA, a known inhibitor of FtsH, counteracted this destruction.

The findings from this bacterial system, which were published in the August 7, 2009, issue of the journal Science, may contribute to a better understanding of cancer therapeutics, since YccA is a functional homologue of the protooncogene product Bax inhibitor-1, which may share a similar mechanism of action in regulating apoptosis in mammalian cells.

"If we are to have any hope of outpacing the antibiotic resistance obtained by bacteria, it is paramount that we fully understand the mechanism of action of the antibiotics we currently use,” said first author Johna van Stelten, a graduate researcher in molecular biology at Princeton University. "Unfortunately, this is often very difficult as evidenced by the fact that, 50 years on, we are still learning new things about them. We have determined how YccA works in preventing stress-induced death in bacteria. We hope this new information will shed light on the mechanism of BI-1 in humans.”

Related Links:
Princeton University




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.